Explainable time-to-progression predictions in multiple sclerosis.

Journal: Computer methods and programs in biomedicine

Publication Year: 

Authors & Co-authors:  D'hondt Robbe R Dedja Klest K Aerts Sofie S Van Wijmeersch Bart B Kalincik Tomas T Reddel Stephen S Havrdova Eva Kubala EK Lugaresi Alessandra A Weinstock-Guttman Bianca B Mrabet Saloua S

A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic.

Journal: Journal of neurology

Publication Year: 

Authors & Co-authors:  Lal Anoushka P AP Foong Yi Chao YC Sanfilippo Paul G PG Spelman Tim T Rath Louise L Levitz David D Fabis-Pedrini Marzena M Foschi Matteo M Habek Mario M Kalincik Tomas T

Early clinical markers of aggressive multiple sclerosis.

Journal: Brain : a journal of neurology

Publication Year: 2020

Authors & Co-authors:  Malpas Charles B CB Manouchehrinia Ali A Sharmin Sifat S Roos Izanne I Horakova Dana D Havrdova Eva Kubala EK Trojano Maria M Izquierdo Guillermo G Eichau Sara S Bergamaschi Roberto R

Comparative effectiveness in multiple sclerosis: A methodological comparison.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Publication Year: 2023

Authors & Co-authors:  Roos Izanne I Diouf Ibrahima I Sharmin Sifat S Horakova Dana D Havrdova Eva Kubala EK Patti Francesco F Shaygannejad Vahid V Ozakbas Serkan S Izquierdo Guillermo G Eichau Sara S

Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Publication Year: 2023

Authors & Co-authors:  Daruwalla Cyrus C Shaygannejad Vahid V Ozakbas Serkan S Havrdova Eva Kubala EK Horakova Dana D Alroughani Raed R Boz Cavit C Patti Francesco F Onofrj Marco M Lugaresi Alessandra A

The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.

Journal: Brain : a journal of neurology

Publication Year: 2023

Authors & Co-authors:  Sharmin Sifat S Roos Izanne I Simpson-Yap Steve S Malpas Charles C Sánchez Marina M MM Ozakbas Serkan S Horakova Dana D Havrdova Eva K EK Patti Francesco F Alroughani Raed R

Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.

Journal: JAMA neurology

Publication Year: 2023

Authors & Co-authors:  Kalincik Tomas T Sharmin Sifat S Roos Izanne I Freedman Mark S MS Atkins Harold H Burman Joachim J Massey Jennifer J Sutton Ian I Withers Barbara B Macdonell Richard R

Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies.

Journal: Journal of neurology

Publication Year: 2024

Authors & Co-authors:  Li Ying Y Saul Alice A Taylor Bruce B Ponsonby Anne-Louise AL Simpson-Yap Steve S Blizzard Leigh L Broadley Simon S Lechner-Scott Jeannette J Karabudak Rana R